Cancer Family
Genitourinary System Neoplasm
CI-CAN-00000018Explore in graph →
Non-malignant3,849 active trials61 approved drugs306 evidence items
- NCIt
- C156482
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000018Explore in graph →
Clinical trials
17,388 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01204749 | TRINOVA-1: A Study of AMG 386 or Placebo, in Combination With Weekly Paclitaxel Chemotherapy, as Treatment for Ovarian Cancer, Primary Peritoneal Cancer and Fallopian Tube Cancer | completed | Phase 3 | 919 | AmgenINDUSTRY | 32 | Dec 15, 2016 | clinicaltrials |
| NCT00928434 | A Study of Degarelix in Patients With Prostate Cancer | completed | Phase 3 | 409 | Ferring PharmaceuticalsINDUSTRY | 1 | Dec 13, 2016 | clinicaltrials |
| NCT01410565 | Efficacy and Safety of Multi-Instillations of Apaziquone in Patients With Non-Muscle Invasive Bladder Cancer | terminated | Phase 3 | 66 | Spectrum Pharmaceuticals, IncINDUSTRY | 2 | Dec 13, 2016 | clinicaltrials |
| NCT00043069 | Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer | completed | Phase 3 | 71 | Alliance for Clinical Trials in OncologyOTHER | 2 | Dec 7, 2016 | clinicaltrials |
| NCT00039338 | Chemotherapy Followed By Surgery Vs Radiotherapy Plus Chemotherapy in Patients With Stage IB or II Cervical Cancer | unknown | Phase 3 | 686 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 8 | Dec 5, 2016 | clinicaltrials |
| NCT02934685 | IG-VMAT for Localized Prostate Cancer | unknown | Phase 3 | 60 | Beijing HospitalOTHER_GOV | 1 | Nov 18, 2016 | clinicaltrials |
| NCT02957266 | Cervical Cancer Radiotherapy by Use of VMAT, Individualized Polyradiosensitization and Interstitial Brachytherapy(CERVIPIB) | unknown | Phase 3 | 400 | The National Center of Oncology, AzerbaijanOTHER_GOV | 1 | Nov 15, 2016 | clinicaltrials |
| NCT01283763 | Topical Imiquimod Versus Conization to Treat Cervical Intraepithelial Neoplasia(ITIC2) | terminated | Phase 3 | 95 | Medical University of ViennaOTHER | 1 | Nov 1, 2016 | clinicaltrials |
| NCT02951078 | A Study of Comparing Effects of Thulium Laser en Bloc Resection and Electrical Transurethral Resection of the Non-muscle Invasive Bladder Cancer | unknown | Phase 3 | 172 | Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 0 | Nov 1, 2016 | clinicaltrials |
| NCT02265159 | Intervention Trial Evaluating Focal Therapy Using High Intensity Focused Ultrasound for the Treatment of Prostate Cancer | unknown | Phase 2 / Phase 3 | 100 | University of ZurichOTHER | 1 | Oct 27, 2016 | clinicaltrials |
| NCT01704651 | Accelerating Gastrointestinal Recovery | completed | Phase 3 | 146 | Jamie N. Bakkum-GamezOTHER | 1 | Oct 24, 2016 | clinicaltrials |
| NCT00061178 | Efficacy and Safety Study of rhuMAb VEGF to Treat Metastatic Renal Cell Carcinoma | withdrawn | Phase 3 | 0 | Genentech, Inc.INDUSTRY | 0 | Oct 19, 2016 | clinicaltrials |
| NCT00744497 | Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-resistant Prostate Cancer(READY) | completed | Phase 3 | 1,930 | Bristol-Myers SquibbINDUSTRY | 25 | Oct 17, 2016 | clinicaltrials |
| NCT00553878 | Comparing 0.5 mg Dutasteride vs Placebo Daily in Men Receiving Androgen Ablation Therapy for Prostate Cancer(AVIAS) | completed | Phase 2 / Phase 3 | 100 | Canadian Urology Research ConsortiumOTHER | 1 | Oct 14, 2016 | clinicaltrials |
| NCT01188187 | Comparison of Docetaxel/Prednisone to Docetaxel/Prednisone in Combination With OGX-011 in Men With Prostate Cancer(SYNERGY) | completed | Phase 3 | 1,022 | Achieve Life SciencesINDUSTRY | 12 | Oct 14, 2016 | clinicaltrials |
| NCT01354171 | Active Surveillance Magnetic Resonance Imaging Study(ASIST) | unknown | Phase 3 | 250 | Canadian Urology Research ConsortiumOTHER | 1 | Oct 14, 2016 | clinicaltrials |
| NCT01578655 | Comparison of Cabazitaxel/Prednisone Alone or in Combination With Custirsen for 2nd Line Chemotherapy in Prostate Cancer(AFFINITY) | completed | Phase 3 | 630 | Achieve Life SciencesINDUSTRY | 8 | Oct 12, 2016 | clinicaltrials |
| NCT00861614 | Study of Immunotherapy to Treat Advanced Prostate Cancer | completed | Phase 3 | 988 | Bristol-Myers SquibbINDUSTRY | 27 | Sep 30, 2016 | clinicaltrials |
| NCT00056407 | "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk(REDUCE) | completed | Phase 3 | 8,231 | GlaxoSmithKlineINDUSTRY | 42 | Sep 23, 2016 | clinicaltrials |
| NCT00138008 | Trial to Evaluate Radiotherapy Followed by Endocrine Therapy Vs Endocrine Therapy Alone for PSA Failure After Radical Prostatectomy | completed | Phase 3 | 200 | Haruhiko FukudaOTHER | 1 | Sep 22, 2016 | clinicaltrials |
| NCT00190528 | A Trial of Neoadjuvant Chemotherapy + Surgery vs. Surgery for Bulky Stage I/II Cervical Cancer | terminated | Phase 3 | 200 | Haruhiko FukudaOTHER | 1 | Sep 22, 2016 | clinicaltrials |
| NCT00295789 | Trial of TP Versus TC Regimens for Stage IVb, Persistent, or Recurrent Cervical Cancer (JCOG0505, CC-TPTC-P3) | completed | Phase 3 | 253 | Haruhiko FukudaOTHER | 1 | Sep 22, 2016 | clinicaltrials |
| NCT00437307 | Hycamtin Plus Carboplatin Versus Established Regimens for the Treatment of Ovarian Cancer Relapse(HECTOR) | completed | Phase 3 | 550 | North Eastern German Society of Gynaecological OncologyOTHER | 1 | Sep 22, 2016 | clinicaltrials |
| NCT02367404 | Prospective RCT on Post Prostatectomy Urine Leak | unknown | Phase 3 | 240 | Institut Mutualiste MontsourisOTHER | 1 | Sep 13, 2016 | clinicaltrials |
| NCT00021450 | Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer | completed | Phase 3 | 819 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 11 | Sep 2, 2016 | clinicaltrials |
| NCT01057810 | Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer | completed | Phase 3 | 837 | Bristol-Myers SquibbINDUSTRY | 24 | Aug 18, 2016 | clinicaltrials |
| NCT00691899 | A Study to Assess the Effects of MK0822 in Prolonging Time to First Bone Metastasis in Men With Castration-Resistant Prostate Cancer (0822-030) | withdrawn | Phase 3 | 0 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Aug 12, 2016 | clinicaltrials |
| NCT00028756 | Comparison of Immediate and Delayed Adjuvant Chemotherapy in Treating Patients Who Have Undergone a Radical Cystectomy for Stage III or Stage IV Transitional Cell Carcinoma of the Bladder Urothelium | completed | Phase 3 | 285 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 0 | Aug 2, 2016 | clinicaltrials |
| NCT00406068 | Mycobacterial Cell Wall-DNA Complex in Treatment of BCG-refractory Patients With Non-muscle Invasive Bladder Cancer | completed | Phase 2 / Phase 3 | 129 | Bioniche Life Sciences Inc.INDUSTRY | 2 | Jul 28, 2016 | clinicaltrials |
| NCT00519285 | Aflibercept in Combination With Docetaxel in Metastatic Androgen Independent Prostate Cancer(VENICE) | completed | Phase 3 | 1,224 | SanofiINDUSTRY | 31 | Jul 22, 2016 | clinicaltrials |
| NCT00003734 | Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer | unknown | Phase 3 | 276 | St. Luke's Hospital, IrelandOTHER | 2 | Jul 21, 2016 | clinicaltrials |
| NCT00382811 | OVATURE (OVArian TUmor REsponse) A Phase III Study of Weekly Carboplatin With and Without Phenoxodiol in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer(OVATURE) | completed | Phase 3 | 142 | MEI Pharma, Inc.INDUSTRY | 7 | Jul 18, 2016 | clinicaltrials |
| NCT00014534 | Combination Chemotherapy in Treating Patients With Bladder Cancer | completed | Phase 3 | 42 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jul 14, 2016 | clinicaltrials |
| NCT00003623 | High-Dose Multivitamins Compared to a Placebo in Preventing the Recurrence of Cancer in Patients With Early Stage Bladder Cancer | completed | Phase 3 | 21 | Alliance for Clinical Trials in OncologyOTHER | 2 | Jul 13, 2016 | clinicaltrials |
| NCT00003674 | Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Prostate Cancer | completed | Phase 3 | 141 | Alliance for Clinical Trials in OncologyOTHER | 2 | Jul 13, 2016 | clinicaltrials |
| NCT00033605 | Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis | completed | Phase 3 | 130 | Alliance for Clinical Trials in OncologyOTHER | 0 | Jul 13, 2016 | clinicaltrials |
| NCT00439751 | Immediate Versus Deferred Androgen Deprivation Therapy,Goserelin for Recurrent Prostate Cancer After Radical Radiotherapy(ELAAT) | completed | Phase 3 | 79 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Jul 12, 2016 | clinicaltrials |
| NCT00023686 | Surgery Versus Internal Radiation in Treating Patients With Stage II Prostate Cancer | completed | Phase 3 | 190 | Alliance for Clinical Trials in OncologyOTHER | 2 | Jul 6, 2016 | clinicaltrials |
| NCT00072046 | Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer) | completed | Phase 3 | 732 | Alliance for Clinical Trials in OncologyOTHER | 2 | Jul 6, 2016 | clinicaltrials |
| NCT00072215 | Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors | terminated | Phase 3 | 1 | Alliance for Clinical Trials in OncologyOTHER | 2 | Jul 4, 2016 | clinicaltrials |
| NCT00002760 | Antiandrogen Withdrawal in Treating Patients With Hormone-Refractory Prostate Cancer | completed | Phase 3 | 260 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jun 28, 2016 | clinicaltrials |
| NCT00028574 | Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer | completed | Phase 3 | 223 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jun 28, 2016 | clinicaltrials |
| NCT00003607 | Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer | completed | Phase 3 | 450 | UNICANCEROTHER | 1 | Jun 23, 2016 | clinicaltrials |
| NCT00003682 | Methylprednisolone With or Without Doxorubicin in Treating Patients With Metastatic Prostate Cancer | terminated | Phase 3 | 160 | UNICANCEROTHER | 1 | Jun 23, 2016 | clinicaltrials |
| NCT00738530 | A Study of Avastin (Bevacizumab) Added to Interferon Alfa-2a (Roferon) Therapy in Patients With Metastatic Renal Cell Cancer With Nephrectomy | completed | Phase 3 | 649 | Hoffmann-La RocheINDUSTRY | 18 | Jun 23, 2016 | clinicaltrials |
| NCT01239732 | A Study of the Addition of Avastin (Bevacizumab) to Carboplatin and Paclitaxel Therapy in Patients With Ovarian Cancer | completed | Phase 3 | 1,021 | Hoffmann-La RocheINDUSTRY | 37 | Jun 10, 2016 | clinicaltrials |
| NCT00216060 | Risedronate to Prevent Skeletal Related Events in Patients With Metastatic Prostate Cancer Commencing Hormonal Therapy | terminated | Phase 3 | 63 | Christopher Sweeney, MBBSOTHER | 2 | May 26, 2016 | clinicaltrials |
| NCT01356329 | Efficacy and Safety of the LovenoxTM (Enoxaparin) Versus HeparinTM Gynecologic Oncology Patients(Lovenox) | suspended | Phase 3 | 150 | National Guard Health AffairsOTHER_GOV | 1 | May 13, 2016 | clinicaltrials |
| NCT00729287 | Selenium in Preventing Cancer Recurrence in Patients With Bladder Cancer(SELEBLAT) | completed | Phase 3 | 276 | KU LeuvenOTHER | 1 | May 12, 2016 | clinicaltrials |
| NCT00529464 | Spectroscopy Versus Standard Care in Cervical Cancer Patients | terminated | Phase 3 | 2 | M.D. Anderson Cancer CenterOTHER | 2 | May 9, 2016 | clinicaltrials |
Data updated 23 days agoSource updated Dec 15, 2016source: clinicaltrials